2025 FDA Updates

Keynote Presentation: Clinical Pharmacology Evaluations of Immunogenicity Impact: Ongoing Efforts to Facilitate Harmonization
Yow-Ming Wang, PhD, Associate Director for Biosimilars and Therapeutic Biologics, CDER, FDA

View Agenda

The Sex Gap in Gene Therapy: How Biological Sex Shapes AAV Immunogenicity from Preexisting Immunity to Innate Activation
Ronit Mazor, PhD, Principal Investigator, CBER, FDA

View Agenda

FDA Perspective on Immunogenicity of Gene Therapy Products
Anurag Sharma, PhD, Chief, Gene Therapy Branch, CBER, FDA

View Agenda